Fine Foods & Pharmaceuticals N.T.M. S.p.A.

BIT:FF Rapport sur les actions

Capitalisation boursière : €204.2m

Fine Foods & Pharmaceuticals N.T.M Bilan de santé

Santé financière contrôle des critères 4/6

Fine Foods & Pharmaceuticals N.T.M has a total shareholder equity of €128.4M and total debt of €61.5M, which brings its debt-to-equity ratio to 47.9%. Its total assets and total liabilities are €239.8M and €111.4M respectively. Fine Foods & Pharmaceuticals N.T.M's EBIT is €9.8M making its interest coverage ratio 2.4. It has cash and short-term investments of €15.2M.

Informations clés

47.9%

Ratio d'endettement

€61.53m

Dette

Ratio de couverture des intérêts2.4x
Argent liquide€15.21m
Fonds propres€128.40m
Total du passif€111.41m
Total des actifs€239.81m

Mises à jour récentes de la santé financière

Recent updates

Solid Earnings Reflect Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Strength As A Business

Sep 20
Solid Earnings Reflect Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Strength As A Business

Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?

Apr 28
Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?

Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Mar 20
Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend

Feb 22
Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend

A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns

Feb 01
A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns

What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition

Jan 14
What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition

We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide

Dec 28
We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Dec 08
Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Analyse de la situation financière

Passif à court terme: FF's short term assets (€106.4M) exceed its short term liabilities (€67.6M).

Passif à long terme: FF's short term assets (€106.4M) exceed its long term liabilities (€43.8M).


Historique et analyse du ratio d'endettement

Niveau d'endettement: FF's net debt to equity ratio (36.1%) is considered satisfactory.

Réduire la dette: FF's debt to equity ratio has increased from 21.4% to 47.9% over the past 5 years.

Couverture de la dette: FF's debt is well covered by operating cash flow (64.9%).

Couverture des intérêts: FF's interest payments on its debt are not well covered by EBIT (2.4x coverage).


Bilan


Découvrir des entreprises saines